Hepatitis B — Ghana

High prevalence, routine infant vaccination from six weeks, and a birth dose that is not universal.

Illustration: Hepatitis B — Ghana

The legal framework

Hepatitis B is highly prevalent in Ghana, with several per cent of adults chronically infected. Vaccination is part of routine immunisation from six weeks in the combined vaccine, but a universal birth dose is not in place, leaving perinatal transmission incompletely addressed. Treatment is available in teaching hospitals, generally at the patient's cost.

Ghana includes hepatitis B in the pentavalent vaccine from six weeks of age but does not give a universal birth dose, so perinatal transmission remains possible. Prevalence is high, and the National Health Insurance Scheme's coverage of antiviral treatment has been a long-standing point of advocacy, since the drugs themselves are inexpensive.

Key points

PrevalenceHigh: several per cent of adults are chronic carriers
VaccinationRoutine from six weeks in the combined vaccine
Birth doseNot universally implemented
Antenatal screeningIncreasingly offered, not universal
TreatmentIn teaching hospitals, usually at the patient's cost
National health insuranceCovers some related care but not all antiviral treatment
Blood safetyDonated blood is screened

In practice

Cost and coverage

Routine immunisation is free; testing and antiviral treatment usually are not.

Where to go

Worth knowing

Vaccinating the household of a carrier is inexpensive and prevents most onward transmission. It is the step most often skipped.

Frequently asked questions

Is treatment covered in Ghana?

Coverage of antiviral treatment for chronic hepatitis B under the insurance scheme has been limited, which means many patients pay out of pocket for drugs that are cheap to produce. Advocacy for inclusion continues; ask at a teaching hospital's liver clinic about current arrangements.

Why does the birth dose matter so much?

Because transmission from mother to baby at birth is the route most likely to produce a lifelong chronic infection — an infant infected at birth has a very high chance of never clearing the virus, whereas an adult usually does. A vaccine dose within twenty-four hours of birth, with immunoglobulin where the mother is positive, prevents this in the great majority of cases.

Official sources and links

← All countries Hepatitis B →

Page checked in September 2026. The instruments cited can change: if in doubt, confirm with the official source given.

Locate this page in the site map

A question, a correction, a suggestion? Write to us.